Oncotarget

Research Papers:

MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5

Tianyuan Xu, Liang Qin, Zhaowei Zhu, Xianjin Wang, Yue Liu, Yong Fan, Shan Zhong, Xiaojing Wang, Xiaohua Zhang, Leilei Xia, Xiang Zhang, Chen Xu and Zhoujun Shen _

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:27445-27457. https://doi.org/10.18632/oncotarget.8479

Metrics: PDF 1796 views  |   HTML 2767 views  |   ?  


Abstract

Tianyuan Xu1,*, Liang Qin1,*, Zhaowei Zhu2, Xianjin Wang1, Yue Liu3, Yong Fan3, Shan Zhong1, Xiaojing Wang1, Xiaohua Zhang1, Leilei Xia1, Xiang Zhang1, Chen Xu3, Zhoujun Shen1

1Department of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

2Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

3Shanghai Key Laboratory of Reproductive Medicine, School of Medicine, Shanghai Jiaotong University, Shanghai, China

*These authors contributed equally to this work

Correspondence to:

Zhoujun Shen, email: [email protected]

Keywords: microRNA-31, integrin α5, bladder cancer, chemotherapy, mitomycin-C

Received: January 09, 2016     Accepted: March 16, 2016     Published: March 30, 2016

ABSTRACT

Urothelial bladder cancer (UBC) is a common genitourinary malignancy. MiR-31, a well-identified miRNA, exhibits diverse properties in different cancers. However, the specific functions and mechanisms of miR-31 in UBC have not been investigated. In this study, tumor samples, especially invasive UBC, showed significantly reduced level of miR-31, as compared with normal urothelium. Prognostic analysis using the EORTC model showed that down-regulation of miR-31 correlated with higher risks of recurrence and progression in noninvasive UBC cases. Remarkably, overexpression of miR-31 mimics in UBC cell lines inhibited cell proliferation, migration and invasion. Integrin α5 (ITGA5), an integrin family member, was subsequently identified as a direct target of miR-31 in UBC cells. When treated with mitomycin-C (MMC), miR-31-expressing UBC cells displayed lower survival and higher apoptotic rates, and deactivated Akt and ERK. These effects arising from miR-31 overexpression were abrogated by ITGA5 restoration. Furthermore, miR-31 markedly inhibited tumor growth and increased the effectiveness of MMC in UBC xenografts. In summary, our data suggest that miR-31 is a prognostic predictor and can serve as a potential therapeutic target of UBC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8479